Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.59 |
| ▸ | LMNA | P02545 | 3/20 | 0.59 |
| ▸ | HTT | P42858 | 3/20 | 0.59 |
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.59 |
| ▸ | S100B | P04271 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.43 |
| ▸ | MPI | P34949 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1115798 | 0.89 | MAPT (0.76) | MAPTLMNAHTTATAD2KDM4E | |
| SCHEMBL12314599 | 0.88 | MAPT (0.50) | MAPTLMNAHTTATAD2KDM4E | |
| SCHEMBL1115720 | 0.85 | MAPT (0.47) | MAPTLMNAHTTATAD2KDM4E | |
| SCHEMBL30349789 | 0.84 | MAPT (0.61) | MAPTLMNAHTTATAD2KDM4E | |
| SCHEMBL28991107 | 0.80 | MAPT (0.61) | MAPTLMNAHTTKDM4ENPSR1 | |
| SCHEMBL15005983 | 0.79 | MAPT (0.59) | MAPTLMNAHTTKDM4ENPSR1 | |
| SCHEMBL15324212 | 0.79 | MAPT (0.59) | MAPTLMNAHTTKDM4ENPSR1 | |
| SCHEMBL30896387 | 0.79 | MAPT (0.59) | MAPTLMNAHTTATAD2KDM4E | |
| SCHEMBL1115528 | 0.77 | ALDH1A1 (0.42) | MAPTLMNAHTTKDM4ENPSR1 | |
| SCHEMBL8129306 | 0.77 | MAPT (0.42) | MAPTLMNAHTTATAD2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4741395-A1 | NOVEL COMPOUND SENSITIVE TO NITROGEN MONOXIDE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Omniamed Co. Ltd (KR) | 2026-05-13 | — | — | EP | disclosed |
| WO-2025009922-A1 | NOVEL COMPOUND SENSITIVE TO NITROGEN MONOXIDE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | 주식회사 옴니아메드 | 2025-01-09 | — | — | WO | disclosed |
| US-8262949-B2 | Long wavelength shifted benzotriazole uv-absorbers and their use | BASF SE (DE) | 2012-09-11 | — | — | US | disclosed |
| US-8262949-B2 | Long wavelength shifted benzotriazole uv-absorbers and their use | BASF SE (DE) | 2012-09-11 | — | — | US | disclosed |
| US-8262949-B2 | Long wavelength shifted benzotriazole uv-absorbers and their use | BASF SE (DE) | 2012-09-11 | — | — | US | disclosed |
| EP-2032577-B1 | LONG WAVELENGTH SHIFTED BENZOTRIAZOLE UV-ABSORBERS AND THEIR USE | BASF SE (DE) | 2011-02-02 | — | — | EP | disclosed |
| US-20100163813-A1 | Long wavelength shifted benzotriazole uv-absorbers and their use | CIBA CORPORATION | 2010-07-01 | — | — | US | disclosed |
| US-20100163813-A1 | Long wavelength shifted benzotriazole uv-absorbers and their use | CIBA CORPORATION | 2010-07-01 | — | — | US | disclosed |
| US-20100163813-A1 | Long wavelength shifted benzotriazole uv-absorbers and their use | CIBA CORPORATION | 2010-07-01 | — | — | US | disclosed |
| EP-2032577-A1 | LONG WAVELENGTH SHIFTED BENZOTRIAZOLE UV-ABSORBERS AND THEIR USE | Ciba Holding Inc. (CH) | 2009-03-11 | — | — | EP | disclosed |
| WO-2008000646-A1 | LONG WAVELENGTH SHIFTED BENZOTRIAZOLE UV-ABSORBERS AND THEIR USE | CIBA HOLDING INC. (CH) | 2008-01-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100163813-A1 | Long wavelength shifted benzotriazole uv-absorbers and their use | SULT1A1, GABBR1, TPMT | MAPT 136/4885LMNA 1593/4885HTT 292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.